This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Hematology/ Hematologic Malignancies  • Endocrine Surgery  • Alert me on articles by topic

Tamara K. Jemcov, MD; Marijana Petakov, MD, PhD; Andrija Bogdanovic, MD; Ljubica Djukanovic, MD, PhD; Visnja D. Lezaic, MD, PhD

Arch Surg. 2008;143(1):97-98.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We have read with great interest the article written by Chow and coworkers¹ showing that anemia improved after total parathyroidectomy (PTX), especially in the patients who received therapy with human recombinant erythropoietin. As the mechanisms for the improvement were not considered in the article, we would like to share our results concerning increased erythropoiesis after PTX, even though they were obtained from an investigation of a small patient group.

Nine patients (5 men; mean [SD] age, 45.0 [15.4] years) who had been receiving regular hemodialysis for 76.8 [43.8] months were included in the study after subtotal PTX. All of them gave informed consent to participate in the study. Indication for PTX was based on clinical, biochemical, and radiological criteria.² Three patients (patients 6, 7, and 8 in the Table) . . . [Full Text of this Article]

AUTHOR INFORMATION